Showing 1 posts of 1 posts found.
ARTBIO, a radiopharma company developing radioligand therapies (RLTs), has appointed four new members to its board of directors and formed …
NEC joins €6.5m European project using AI for pandemic vaccine design
The evidence bar impacting UK medical cannabis access
Survey highlights mental health burden among rare disease patients and families
Addressing the rheumatic disease diagnostic gap in primary care
How chronic disease creates opportunity on diagnostic and therapeutic pipelines